{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:37:17Z","timestamp":1786981037148,"version":"build-2736575974"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-024-02160-w","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T08:02:45Z","timestamp":1728892965000},"page":"1863-1878","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Protective Effects of a Dihydrodiazepine Against Endotoxin Shock Through Suppression of TLR4\/NF-\u03baB\/IRF3 Signaling Pathways"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9230-3858","authenticated-orcid":false,"given":"Hamza","family":"Hanieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal A.","family":"Alfwuaires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maisa S.","family":"Abduh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyaa","family":"Abdrabu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidal A.","family":"Qinna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah M.","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,14]]},"reference":[{"key":"2160_CR1","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41420-023-01766-7","volume":"9","author":"M Cao","year":"2023","unstructured":"Cao, M., G. Wang, and J. Xie. 2023. Immune dysregulation in sepsis: Experiences, lessons and perspectives. Cell Death Discovery 9: 465.","journal-title":"Cell Death Discovery"},{"key":"2160_CR2","first-page":"409","volume":"101","author":"R Gauer","year":"2020","unstructured":"Gauer, R., D. Forbes, and N. Boyer. 2020. Sepsis: Diagnosis and management. American Family Physician 101: 409\u2013418.","journal-title":"American Family Physician"},{"key":"2160_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2016.45","volume":"2","author":"RS Hotchkiss","year":"2016","unstructured":"Hotchkiss, R.S., L.L. Moldawer, S.M. Opal, K. Reinhart, I.R. Turnbull, and J.-L. Vincent. 2016. Sepsis and septic shock. Nature Reviews Disease Primers 2: 1\u201321.","journal-title":"Nature Reviews Disease Primers"},{"key":"2160_CR4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd, K.E., S.C. Johnson, K.M. Agesa, K.A. Shackelford, D. Tsoi, D.R. Kievlan, et al. 2020. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: Analysis for the Global Burden of Disease Study. The Lancet 395: 200\u2013211.","journal-title":"The Lancet"},{"key":"2160_CR5","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer, M., C.S. Deutschman, C.W. Seymour, M. Shankar-Hari, D. Annane, M. Bauer, et al. 2016. The third international consensus definitions for sepsis and septic shock (Sepsis-3). Journal of the American Medical Association 315: 801\u2013810.","journal-title":"Journal of the American Medical Association"},{"key":"2160_CR6","doi-asserted-by":"publisher","first-page":"107791","DOI":"10.1016\/j.intimp.2021.107791","volume":"96","author":"X Chen","year":"2021","unstructured":"Chen, X., Y. Liu, Y. Gao, S. Shou, and Y. Chai. 2021. The roles of macrophage polarization in the host immune response to sepsis. International Immunopharmacology 96: 107791.","journal-title":"International Immunopharmacology"},{"key":"2160_CR7","doi-asserted-by":"publisher","first-page":"1336813","DOI":"10.3389\/fimmu.2024.1336813","volume":"15","author":"B Basak","year":"2024","unstructured":"Basak, B., and S. Akashi-Takamura. 2024. IRF3 function and immunological gaps in sepsis. Frontiers in Immunology 15: 1336813.","journal-title":"Frontiers in Immunology"},{"key":"2160_CR8","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/cbf.3790","volume":"41","author":"A Okan","year":"2023","unstructured":"Okan, A., Z. Do\u011fanyi\u011fit, S. Yilmaz, S. U\u00e7ar, E.S. Arikan S\u00f6ylemez, and R. Attar. 2023. Evaluation of the protective role of resveratrol against sepsis caused by LPS via TLR4\/NF-\u03baB\/TNF-\u03b1 signaling pathways: Experimental study. Cell Biochemistry and Function 41: 423\u2013433.","journal-title":"Cell Biochemistry and Function"},{"key":"2160_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejphar.2015.12.030","volume":"772","author":"H Vaez","year":"2016","unstructured":"Vaez, H., M. Rameshrad, M. Najafi, J. Barar, A. Barzegari, and A. Garjani. 2016. Cardioprotective effect of metformin in lipopolysaccharide-induced sepsis via suppression of toll-like receptor 4 (TLR4) in heart. European Journal of Pharmacology 772: 115\u2013123.","journal-title":"European Journal of Pharmacology"},{"key":"2160_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10787-024-01530-y","volume":"32","author":"AM AlZahrani","year":"2024","unstructured":"AlZahrani, A.M., P. Rajendran, G.M. Bekhet, R. Balasubramanian, L.K. Govindaram, E.A. Ahmed, et al. 2024. Protective effect of 5, 4\u2019-dihydroxy-6, 8-dimethoxy7-O-rhamnosylflavone from Indigofera aspalathoides Vahl on lipopolysaccharide-induced intestinal injury in mice. Inflammopharmacology 32: 1\u201315.","journal-title":"Inflammopharmacology"},{"key":"2160_CR11","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.3389\/fimmu.2020.01210","volume":"11","author":"A Romerio","year":"2020","unstructured":"Romerio, A., and F. Peri. 2020. Increasing the chemical variety of small-molecule-based TLR4 modulators: An overview. Frontiers in Immunology 11: 1210.","journal-title":"Frontiers in Immunology"},{"key":"2160_CR12","doi-asserted-by":"publisher","first-page":"116300","DOI":"10.1016\/j.ejmech.2024.116300","volume":"268","author":"Y Zheng","year":"2024","unstructured":"Zheng, Y., Y. Gao, W. Zhu, X.-G. Bai, and J. Qi. 2024. Advances in molecular agents targeting toll-like receptor 4 signaling pathways for potential treatment of sepsis. European Journal of Medicinal Chemistry 268: 116300.","journal-title":"European Journal of Medicinal Chemistry"},{"key":"2160_CR13","first-page":"5020","volume":"23","author":"Y Jin","year":"2019","unstructured":"Jin, Y., Z. Li, H. Chen, X. Jiang, Y. Zhang, and F. Wu. 2019. Effect of dexmedetomidine on kidney injury in sepsis rats through TLR4\/MyD88\/NF-\u03baB\/iNOS signaling pathway. European Review for Medical and Pharmacological Sciences 23: 5020\u20135025.","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"2160_CR14","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.3892\/mmr.2015.3925","volume":"12","author":"K Zhang","year":"2015","unstructured":"Zhang, K., X.F. Jiao, J.X. Li, and X.W. Wang. 2015. Rhein inhibits lipopolysaccharide-induced intestinal injury during sepsis by blocking the toll-like receptor 4 nuclear factor-\u03baB pathway. Molecular Medicine Reports 12: 4415\u20134421.","journal-title":"Molecular Medicine Reports"},{"key":"2160_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.taap.2016.11.015","volume":"315","author":"F Lambertucci","year":"2017","unstructured":"Lambertucci, F., O. Moti\u00f1o, S. Villar, J.P. Rigalli, M. de Luj\u00e1n Alvarez, V.A. Catania, et al. 2017. Benznidazole, the trypanocidal drug used for Chagas disease, induces hepatic NRF2 activation and attenuates the inflammatory response in a murine model of sepsis. Toxicology and Applied Pharmacology 315: 12\u201322.","journal-title":"Toxicology and Applied Pharmacology"},{"key":"2160_CR16","doi-asserted-by":"publisher","first-page":"119662","DOI":"10.1016\/j.lfs.2021.119662","volume":"279","author":"IE Yildiz","year":"2021","unstructured":"Yildiz, I.E., A. Topcu, I. Bahceci, M. Arpa, L. Tumkaya, T. Mercantepe, et al. 2021. The protective role of fosfomycin in lung injury due to oxidative stress and inflammation caused by sepsis. Life Sciences 279: 119662.","journal-title":"Life Sciences"},{"key":"2160_CR17","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.chembiol.2014.03.004","volume":"21","author":"SG Smith","year":"2014","unstructured":"Smith, S.G., R. Sanchez, and M.-M. Zhou. 2014. Privileged diazepine compounds and their emergence as bromodomain inhibitors. Chemistry & Biology 21: 573\u2013583.","journal-title":"Chemistry & Biology"},{"key":"2160_CR18","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10620-018-5309-8","volume":"64","author":"KF Castro-Ochoa","year":"2019","unstructured":"Castro-Ochoa, K.F., H. Vargas-Robles, S. Ch\u00e1nez-Paredes, A. Felipe-L\u00f3pez, R.I. Cabrera-Silva, M. Shibayama, et al. 2019. Homoectoine protects against colitis by preventing a claudin switch in epithelial tight junctions. Digestive Diseases and Sciences 64: 409\u2013420.","journal-title":"Digestive Diseases and Sciences"},{"key":"2160_CR19","unstructured":"Adachi K, Hikawa H, Hamada M, Endoh J-i, Ishibuchi S, Fujie N, et al. Thienotriazolodiazepine compound and medicinal use thereof: Google Patents, 2011."},{"key":"2160_CR20","unstructured":"Miyoshi S, Ooike S, Iwata K, Hikawa H, Sugahara K. Antitumor Agent, citMitsubishi Tanabe Pharma Corporation. Japan[Google Scholar] 2008."},{"key":"2160_CR21","doi-asserted-by":"publisher","first-page":"80288","DOI":"10.18632\/oncotarget.13375","volume":"7","author":"A Zech","year":"2016","unstructured":"Zech, A., B. Wiesler, C.K. Ayata, T. Schlaich, T. D\u00fcrk, M. Ho\u00dffeld, et al. 2016. P2rx4 deficiency in mice alleviates allergen-induced airway inflammation. Oncotarget 7: 80288.","journal-title":"Oncotarget"},{"key":"2160_CR22","doi-asserted-by":"publisher","first-page":"682612","DOI":"10.3389\/fimmu.2021.682612","volume":"12","author":"CR Falc\u00f3n","year":"2021","unstructured":"Falc\u00f3n, C.R., N.F. Hurst, A.L. Vivinetto, P.H.H. L\u00f3pez, A. Zurita, G. Gatti, et al. 2021. Diazepam impairs innate and adaptive immune responses and ameliorates experimental autoimmune encephalomyelitis. Frontiers in Immunology 12: 682612.","journal-title":"Frontiers in Immunology"},{"key":"2160_CR23","doi-asserted-by":"publisher","first-page":"11543","DOI":"10.1073\/pnas.1613307113","volume":"113","author":"MM-U Zaman","year":"2016","unstructured":"Zaman, M.M.-U., K. Masuda, K.K. Nyati, P.K. Dubey, B. Ripley, K. Wang, et al. 2016. Arid5a exacerbates IFN-\u03b3\u2013mediated septic shock by stabilizing T-bet mRNA. Proceedings of the National Academy of Sciences 113: 11543\u201311548.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"2160_CR24","doi-asserted-by":"publisher","first-page":"e76094","DOI":"10.7554\/eLife.76094","volume":"11","author":"W-J Luo","year":"2022","unstructured":"Luo, W.-J., S.-L. Yu, C.-C. Chang, M.-H. Chien, Y.-L. Chang, K.-M. Liao, et al. 2022. HLJ1 amplifies endotoxin-induced sepsis severity by promoting IL-12 heterodimerization in macrophages. eLife 11: e76094.","journal-title":"eLife"},{"key":"2160_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-0500-7-233","volume":"7","author":"B Shrum","year":"2014","unstructured":"Shrum, B., R.V. Anantha, S.X. Xu, M. Donnelly, S.M. Haeryfar, J.K. McCormick, et al. 2014. A robust scoring system to evaluate sepsis severity in an animal model. BMC Research Notes 7: 1\u201311.","journal-title":"BMC Research Notes"},{"key":"2160_CR26","doi-asserted-by":"publisher","first-page":"8900","DOI":"10.1038\/ncomms9900","volume":"6","author":"F Ferri","year":"2015","unstructured":"Ferri, F., A. Parcelier, V. Petit, A.-S. Gallouet, D. Lewandowski, M. Dalloz, et al. 2015. TRIM33 switches off Ifnb1 gene transcription during the late phase of macrophage activation. Nature Communications 6: 8900.","journal-title":"Nature Communications"},{"key":"2160_CR27","unstructured":"Information NCfB. 2-[7-(Trifluoromethyl)-2,3-dihydro-1H-1,4-diazepin-5-yl]phenol: PubChem, 2024."},{"key":"2160_CR28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41581-018-0005-7","volume":"14","author":"C Lelubre","year":"2018","unstructured":"Lelubre, C., and J.-L. Vincent. 2018. Mechanisms and treatment of organ failure in sepsis. Nature Reviews Nephrology 14: 417\u2013427.","journal-title":"Nature Reviews Nephrology"},{"key":"2160_CR29","doi-asserted-by":"publisher","first-page":"624279","DOI":"10.3389\/fimmu.2020.624279","volume":"11","author":"Y Nakamori","year":"2021","unstructured":"Nakamori, Y., E.J. Park, and M. Shimaoka. 2021. Immune deregulation in sepsis and septic shock: Reversing immune paralysis by targeting PD-1\/PD-L1 pathway. Frontiers in Immunology 11: 624279.","journal-title":"Frontiers in Immunology"},{"key":"2160_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/08830185.2021.1884247","volume":"41","author":"Y-C Liu","year":"2022","unstructured":"Liu, Y.-C., S.-T. Shou, and Y.-F. Chai. 2022. Immune checkpoints in sepsis: New hopes and challenges. International Reviews of Immunology 41: 207\u2013216.","journal-title":"International Reviews of Immunology"},{"key":"2160_CR31","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.cell.2015.10.054","volume":"163","author":"KE Pauken","year":"2015","unstructured":"Pauken, K.E., and E.J. Wherry. 2015. SnapShot: T cell exhaustion. Cell 163: 1038-1038. e1.","journal-title":"Cell"},{"key":"2160_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40635-019-0236-3","volume":"7","author":"AM Garofalo","year":"2019","unstructured":"Garofalo, A.M., M. Lorente-Ros, G. Goncalvez, D. Carriedo, A. Ball\u00e9n-Barrag\u00e1n, A. Villar-Fern\u00e1ndez, et al. 2019. Histopathological changes of organ dysfunction in sepsis. Intensive Care Medicine Experimental 7: 1\u201315.","journal-title":"Intensive Care Medicine Experimental"},{"key":"2160_CR33","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.3390\/ijms25031902","volume":"25","author":"J Yang","year":"2024","unstructured":"Yang, J., X. Zhu, and J. Feng. 2024. The Changes in the Quantity of Lymphocyte Subpopulations during the Process of Sepsis. International Journal of Molecular Sciences 25: 1902.","journal-title":"International Journal of Molecular Sciences"},{"key":"2160_CR34","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1164\/rccm.201504-0781OC","volume":"193","author":"C Fleischmann","year":"2016","unstructured":"Fleischmann, C., A. Scherag, N.K. Adhikari, C.S. Hartog, T. Tsaganos, P. Schlattmann, et al. 2016. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. American Journal of Respiratory and Critical Care Medicine 193: 259\u2013272.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"2160_CR35","doi-asserted-by":"publisher","first-page":"12732","DOI":"10.3390\/ijms241612732","volume":"24","author":"J Su","year":"2023","unstructured":"Su, J., F. Zhou, S. Wu, and Z. Tong. 2023. Research Progress on Natural Small-Molecule Compounds for the Prevention and Treatment of Sepsis. International Journal of Molecular Sciences 24: 12732.","journal-title":"International Journal of Molecular Sciences"},{"key":"2160_CR36","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.intimp.2018.11.050","volume":"66","author":"Y Horiguchi","year":"2019","unstructured":"Horiguchi, Y., N. Ohta, S. Yamamoto, M. Koide, and Y. Fujino. 2019. Midazolam suppresses the lipopolysaccharide-stimulated immune responses of human macrophages via translocator protein signaling. International Immunopharmacology 66: 373\u2013382.","journal-title":"International Immunopharmacology"},{"key":"2160_CR37","doi-asserted-by":"publisher","first-page":"165974","DOI":"10.1155\/2013\/165974","volume":"2013","author":"W Schulte","year":"2013","unstructured":"Schulte, W., J. Bernhagen, and R. Bucala. 2013. Cytokines in sepsis: Potent immunoregulators and potential therapeutic targets\u2014an updated view. Mediators of Inflammation 2013: 165974.","journal-title":"Mediators of Inflammation"},{"key":"2160_CR38","first-page":"2162","volume":"136","author":"P Tsoukas","year":"2020","unstructured":"Tsoukas, P., E. Rapp, L. Van Der Kraak, E.S. Weiss, V. Dang, C. Schneider, et al. 2020. Interleukin-18 and cytotoxic impairment are independent and synergistic causes of murine virus-induced hyperinflammation. Blood, The Journal of the American Society of Hematology 136: 2162\u20132174.","journal-title":"Blood, The Journal of the American Society of Hematology"},{"key":"2160_CR39","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3389\/fimmu.2014.00614","volume":"5","author":"N Wang","year":"2014","unstructured":"Wang, N., H. Liang, and K. Zen. 2014. Molecular mechanisms that influence the macrophage M1\u2013M2 polarization balance. Frontiers in Immunology 5: 614.","journal-title":"Frontiers in Immunology"},{"key":"2160_CR40","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.1128\/IAI.70.8.4441-4446.2002","volume":"70","author":"SQ Latifi","year":"2002","unstructured":"Latifi, S.Q., M.A. O\u2019Riordan, and A.D. Levine. 2002. Interleukin-10 controls the onset of irreversible septic shock. Infection and Immunity 70: 4441\u20134446.","journal-title":"Infection and Immunity"},{"key":"2160_CR41","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1365-2567.2004.01976.x","volume":"113","author":"EM P\u00e5lsson-McDermott","year":"2004","unstructured":"P\u00e5lsson-McDermott, E.M., and L.A. O\u2019Neill. 2004. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 113: 153\u2013162.","journal-title":"Immunology"},{"key":"2160_CR42","first-page":"1824","volume":"19","author":"W Tong","year":"2020","unstructured":"Tong, W., X. Chen, X. Song, Y. Chen, R. Jia, Y. Zou, et al. 2020. Resveratrol inhibits LPS-induced inflammation through suppressing the signaling cascades of TLR4-NF-\u03baB\/MAPKs\/IRF3. Experimental and Therapeutic Medicine 19: 1824\u20131834.","journal-title":"Experimental and Therapeutic Medicine"},{"key":"2160_CR43","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00011-016-0932-3","volume":"65","author":"L Jiang","year":"2016","unstructured":"Jiang, L., F. Xu, W. He, L. Chen, H. Zhong, Y. Wu, et al. 2016. CD200Fc reduces TLR4-mediated inflammatory responses in LPS-induced rat primary microglial cells via inhibition of the NF-\u03baB pathway. Inflammation Research 65: 521\u2013532.","journal-title":"Inflammation Research"},{"key":"2160_CR44","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1021\/jm00120a002","volume":"31","author":"B Evans","year":"1988","unstructured":"Evans, B., K. Rittle, M. Bock, R. DiPardo, R. Freidinger, W. Whitter, et al. 1988. Methods for drug discovery: Development of potent, selective, orally effective cholecystokinin antagonists. Journal of Medicinal Chemistry 31: 2235\u20132246.","journal-title":"Journal of Medicinal Chemistry"},{"key":"2160_CR45","doi-asserted-by":"publisher","first-page":"1209438","DOI":"10.3389\/fimmu.2023.1209438","volume":"14","author":"Z Wang","year":"2023","unstructured":"Wang, Z., and Z. Wang. 2023. The role of macrophages polarization in sepsis-induced acute lung injury. Frontiers in Immunology 14: 1209438.","journal-title":"Frontiers in Immunology"},{"key":"2160_CR46","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1089\/sur.2004.5.375","volume":"5","author":"S Newton","year":"2004","unstructured":"Newton, S., Y. Ding, C.-S. Chung, Y. Chen, J.L. Lomas-Neira, and A. Ayala. 2004. Sepsis-induced changes in macrophage co-stimulatory molecule expression: CD86 as a regulator of anti-inflammatory IL-10 response. Surgical Infections 5: 375\u2013383.","journal-title":"Surgical Infections"},{"key":"2160_CR47","doi-asserted-by":"publisher","first-page":"e6600","DOI":"10.1371\/journal.pone.0006600","volume":"4","author":"A Nolan","year":"2009","unstructured":"Nolan, A., H. Kobayashi, B. Naveed, A. Kelly, Y. Hoshino, S. Hoshino, et al. 2009. Differential role for CD80 and CD86 in the regulation of the innate immune response in murine polymicrobial sepsis. PLoS ONE 4: e6600.","journal-title":"PLoS ONE"},{"key":"2160_CR48","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1164\/rccm.200703-515OC","volume":"177","author":"A Nolan","year":"2008","unstructured":"Nolan, A., M. Weiden, A. Kelly, Y. Hoshino, S. Hoshino, N. Mehta, et al. 2008. CD40 and CD80\/86 act synergistically to regulate inflammation and mortality in polymicrobial sepsis. American Journal of Respiratory and Critical Care Medicine 177: 301\u2013308.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"2160_CR49","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1038\/mt.2013.178","volume":"21","author":"K Hoehlig","year":"2013","unstructured":"Hoehlig, K., C. Maasch, N. Shushakova, K. Buchner, M. Huber-Lang, W.G. Purschke, et al. 2013. A novel C5a-neutralizing mirror-image (l-) aptamer prevents organ failure and improves survival in experimental sepsis. Molecular Therapy 21: 2236\u20132246.","journal-title":"Molecular Therapy"},{"key":"2160_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-018-2020-2","volume":"22","author":"JK Wilson","year":"2018","unstructured":"Wilson, J.K., Y. Zhao, M. Singer, J. Spencer, and M. Shankar-Hari. 2018. Lymphocyte subset expression and serum concentrations of PD-1\/PD-L1 in sepsis-pilot study. Critical Care 22: 1\u20137.","journal-title":"Critical Care"},{"key":"2160_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/cc9354","volume":"14","author":"Y Zhang","year":"2010","unstructured":"Zhang, Y., Y. Zhou, J. Lou, J. Li, L. Bo, K. Zhu, et al. 2010. PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction. Critical Care 14: 1\u20139.","journal-title":"Critical Care"},{"key":"2160_CR52","first-page":"1","volume":"23","author":"J Chen","year":"2021","unstructured":"Chen, J., R. Chen, S. Huang, B. Zu, and S. Zhang. 2021. Atezolizumab alleviates the immunosuppression induced by PD-L1-positive neutrophils and improves the survival of mice during sepsis. Molecular Medicine Reports 23: 1\u20131.","journal-title":"Molecular Medicine Reports"},{"key":"2160_CR53","doi-asserted-by":"publisher","first-page":"956448","DOI":"10.3389\/fimmu.2022.956448","volume":"13","author":"N Wang","year":"2022","unstructured":"Wang, N., Y. Lu, J. Zheng, and X. Liu. 2022. Of mice and men: Laboratory murine models for recapitulating the immunosuppression of human sepsis. Frontiers in Immunology 13: 956448.","journal-title":"Frontiers in Immunology"},{"key":"2160_CR54","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40659-023-00469-8","volume":"56","author":"R Bojalil","year":"2023","unstructured":"Bojalil, R., A. Ru\u00edz-Hern\u00e1ndez, A. Villanueva-Arias, L.M. Amezcua-Guerra, S. C\u00e1sarez-Alvarado, A.M. Hern\u00e1ndez-Due\u00f1as, et al. 2023. Two murine models of sepsis: Immunopathological differences between the sexes\u2014possible role of TGF\u03b21 in female resistance to endotoxemia. Biological Research 56: 54.","journal-title":"Biological Research"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-024-02160-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-024-02160-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-024-02160-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T00:38:44Z","timestamp":1757119124000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-024-02160-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,14]]},"references-count":54,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["2160"],"URL":"https:\/\/doi.org\/10.1007\/s10753-024-02160-w","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,14]]},"assertion":[{"value":"20 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}